Xtant Medical Holdings, Inc. (NYSE:XTNT) Q3 2022 Results Conference Call November 3, 2022 9:00 AM ET Company Participants Matt Steinberg - IR, FINN Partners Sean Browne - President and Chief Executive Officer Scott Niels - Chief Financial Officer Operator Greetings, and welcome to the Xtant Medical Q3 2022 Financial Results Conference Call [Operator Instructions]. As a reminder, this conference is being recorded. I would now like to turn the conference over to Matt Steinberg of FINN Partners. Please go ahe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or | Delaware | 20-5313323 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 664 Cruiser Lane | | | Belgrade, Montana | 59714 | | (Address of principal executive offices) | (Zip Code) | | (406) 388-0 ...

Xtant Medical Holdings, Inc. (NYSE:XTNT) Q2 2022 Earnings Conference Call August 4, 2022 9:00 AM ET Company Participants Matt Steinberg - IR, Lazar FINN Partners Sean Browne - President and CEO Scott Neils - CFO Conference Call Participants Operator Greetings and welcome to the Xtant Medical Second Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the con ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securitie ...

Xtant Medical Holdings, Inc. (NYSE:XTNT) Q1 2022 Earnings Conference Call May 5, 2022 9:00 AM ET Company Participants Matt Steinberg - Investor Relations, Lazar FINN Partners Sean Browne - President and Chief Executive Officer Scott Neils - Interim Chief Financial Officer Operator Greetings and welcome to the Xtant Medical First Quarter 2022 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to Matt Steinb ...

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or Commission File Number: 001-34951 XTANT MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) | Delaware | ...

www.xtantmedical.com Investor Presentation March 2022 DISCLOSURE STATEMENTS Cautionary Statement Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "intends," ''expects,'' ''anticipates,'' ''plans,'' "targets," ''believes,'' ''esti ...

Xtant Medical Holdings, Inc. (NYSE:XTNT) Q4 2021 Earnings Conference Call March 8, 2022 9:00 AM ET Company Participants Matt Steinberg - IR, Lazar FINN Partners Sean Browne - President and Chief Executive Officer Scott Neils - Interim CFO Conference Call Participants Operator Greetings and welcome to the Xtant Medical Fourth Quarter and Full-Year 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being r ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-34951 Xtant Medical Holdings, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 20-5313323 ...

Investor Presentation September 2021 www.xtantmedical.com DISCLOSURE STATEMENTS Cautionary Statement Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "intends," ''expects,'' ''anticipates,'' ''plans,'' "targets," ''believes,'' '' ...